“These results are really exciting. This could be a new front in the fight against MS.”
Researchers at Oregon Health & Science University have discovered that an antioxidant designed by scientists more than a dozen years ago to fight damage within human cells significantly helps symptoms in mice that have a multiple sclerosis-like disease.
The antioxidant — called MitoQ — has shown some promise in fighting neurodegenerative diseases. But this is the first time it has been shown to significantly reverse an MS-like disease in an animal.
The discovery could lead to an entirely new way to treat multiple sclerosis, which affects more than 2.3 million people worldwide.
Multiple sclerosis occurs when the body’s immune system attacks the myelin, or the protective sheath, surrounding nerve fibers of the central nervous system. Some underlying nerve fibers are destroyed. Resulting symptoms can include blurred vision and blindness, loss of balance, slurred speech, tremors, numbness and problems with memory and concentration.
The antioxidant research was published in the December edition of Biochimica et Biophysica Acta Molecular Basis of Disease. The research team was led by P. Hemachandra Reddy, Ph.D., an associate scientist in the Division of Neuroscience at OHSU’s Oregon National Primate Research Center.
To conduct their study, the researchers induced mice to contract a disease called experimental autoimmune encephalomyelitis, or EAE, which is very similar to MS in humans. They separated mice into four groups: a group with EAE only; a group that was given the EAE, then treated with the MitoQ; a third group that was given the MitoQ first, then given the EAE; and a fourth “control” group of mice without EAE and without any other treatment.
After 14 days, the EAE mice that had been treated with the MitoQ exhibited reduced inflammatory markers and increased neuronal activity in the spinal cord — an affected brain region in MS — that showed their EAE symptoms were being improved by the treatment. The mice also showed reduced loss of axons, or nerve fibers and reduced neurological disabilities associated with the EAE. The mice that had been pre-treated with the MitoQ showed the least problems. The mice that had been treated with MitoQ after EAE also showed many fewer problems than mice who were just induced to get the EAE and then given no treatment.
“The MitoQ also significantly reduced inflammation of the neurons and reduced demyelination,” Reddy said. “These results are really exciting. This could be a new front in the fight against MS.”
Even if the treatment continues to show promise, testing in humans would be years away. The next steps for Reddy’s team will be to understand the mechanisms of MitoQ neuroprotection in different regions of the brain, and how MitoQ protects mitochondria within the brain cells of the EAE mice. Mitochondria, components within all human cells, convert energy into forms that are usable by the cell.
There is a built-in advantage with MitoQ. Unlike many new drugs, MitoQ has been tested for safety in numerous clinical trails with humans. Since its development in the late 1990s, researchers have tested MitoQ’s ability to decrease oxidative damage in mitochondria.
The Latest on: Multiple sclerosis
via Google News
The Latest on: Multiple sclerosis
- Patients report cannabis eases spasticity in multiple sclerosison February 28, 2020 at 10:19 am
(HealthDay)—Cannabis use is common among multiple sclerosis (MS) patients with spasticity, according to a research letter published online Feb. 11 in Multiple Sclerosis and Related Disorders. Jessica ...
- CorTechs Labs Presents Findings on the Creation of Machine Learning Models to Aid Early, Accurate Diagnosis of Multiple Sclerosis (MS) at ACTRIMS 2020on February 28, 2020 at 9:11 am
CorTechs Labs Inc., the leading quantitative neuroimaging software company, announced today they will be exhibiting at Americas Committee for Treatment & Research in Multiple Sclerosis' (ACTRIMS) 2020 ...
- Multiple Sclerosis Therapeutics Market Offering Long-term Disease Managementon February 28, 2020 at 1:43 am
Global Multiple Sclerosis Therapeutics Market Multiple sclerosis (MS) is a demyelinating disease, in which the ...
- Let's Talk About Multiple Sclerosison February 27, 2020 at 7:01 pm
Whether you’ve just been diagnosed or worry you could have multiple sclerosis (MS), you’re probably nervous, confused, and a little scared. That’s a natural reaction, and everyone featured on ...
- Disrupted principal network organisation in multiple sclerosis relates to disabilityon February 27, 2020 at 2:32 am
Structural network-based approaches can assess white matter connections revealing topological alterations in multiple sclerosis (MS). However, principal network (PN) organisation and its clinical ...
- Multiple Sclerosis (MS) Drugs Market to See Massive Growth by 2025 | Bayer, Bayhill Therapeutics, Biogenon February 27, 2020 at 12:25 am
Global Multiple Sclerosis (MS) Drugs Market Analysis 2015-2019 and Forecast 2020-2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, ...
- Selma Blair Gets Candid About Living With Multiple Sclerosison February 26, 2020 at 4:12 pm
She had roles in iconic films such as Legally Blonde and Cruel Intentions. However, in 2018 the actress revealed she was diagnosed with multiple sclerosis, coming as a shock to both her and her family ...
- Selma Blair Shared How She Found ‘Hope’ After Her Multiple Sclerosis Diagnosison February 26, 2020 at 3:45 pm
In recent years, Blair has become notorious for another reason — her revelation of her multiple sclerosis diagnosis. With friends and fans rallying around Blair as she battles her illness, the actress ...
- Learning to Live With Multiple Sclerosison February 26, 2020 at 2:07 pm
In 2014, Meredith O’Brien was diagnosed with relapse-remitting multiple sclerosis. The author, teacher, wife, and mother had spent more than two years seeking help for symptoms that were scary, ...
- Antioxidant precursor molecule could improve brain function in patients with multiple sclerosison February 26, 2020 at 10:08 am
N-acetylcysteine (NAC) is a naturally occurring molecule that replenishes antioxidants and shows improved brain metabolism and self-reported improvements in cognitive function in patients with ...
via Bing News